Reuven Zimlichman

Medicine & Life Sciences

1. Blood Pressure 100%
2. Elasticity 70%
3. Hypertension 58%
4. Placebos 54%
5. Antihypertensive Agents 49%
6. Norepinephrine 49%
7. Essential Hypertension 44%
8. Hemodynamics 44%
9. Heart Failure 41%
10. Compliance 37%
11. Catecholamines 37%
12. Therapeutics 33%
13. Arteries 33%
14. Cilazapril 30%
15. Israel 29%
16. Inbred SHR Rats 28%
17. Calcium 28%
18. Rivaroxaban 28%
19. Insulin 27%
20. Insulin Glargine 27%
21. Vascular Resistance 25%
22. Blood Vessels 24%
23. Cardiovascular Diseases 23%
24. Myocardial Infarction 23%
25. Hyperinsulinism 22%
26. Impedance Cardiography 22%
27. Arterial Pressure 21%
28. Chromaffin Cells 20%
29. Dronedarone 20%
30. Atrial Fibrillation 20%
31. Inbred WKY Rats 20%
32. Angiotensin II 19%
33. Deoxyglucose 19%
34. Isoproterenol 19%
35. Aspirin 19%
36. Laser-Doppler Flowmetry 18%
37. Mortality 18%
38. Cardiac Output 18%
39. Type 2 Diabetes Mellitus 17%
40. Ketanserin 16%
41. Rosiglitazone 15%
42. Angiotensin Receptor Antagonists 15%
43. Pulse Wave Analysis 15%
44. isobutyric acid 2-(2-((3-(4,7-dimethoxy-1H-benzoimidazol-2-yl)propyl)methylamino)ethyl)-5-phenylbicyclo(2.2.2)oct-5-en-2-yl ester 15%
45. Endothelins 15%
46. Respiration 15%
47. candesartan 15%
48. Heart Rate 15%
49. Cardiology 15%
50. Glucose 15%